NCT04951154View on ClinicalTrials.gov

A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

March 28, 2022

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
OTHER

Bronchoscopic Biopsy

Bronchoscopic biopsies will be used to evaluate biomarkers of tumor biology and immunology.

OTHER

Blood Sample

Blood samples will be obtained to measure circulating biomarkers.

Trial Locations (2)

14263

Roswell Park Comprehensive Cancer Center, Buffalo

20010

Medstar Washington Hospital Center, Washington D.C.

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY